How COVID-19 Will Accelerate A Digital Therapeutics Revolution The principal beneficiary of the digital therapeutics revolution will be the patients that use them. Although it has taken a tragedy like COVID-19 to spur these changes, if the positive ones remain,  it will lead to more options, lower prices, and greater access to innovative treatments.